Trial Profile

Comparison of single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection: A phase III randomized, double-blind study

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 20 Apr 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Peramivir (Primary) ; Oseltamivir
Indications Influenza virus infections
Focus Registrational; Therapeutic Use

Most Recent Events

08 Aug 2011 Status changed from active, no longer recruiting to completed.
26 Feb 2010 The results of this trial supported the approval of peramivir in Japan for the treatment of influenza virus infection.
12 Sep 2009 Results have been reported at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com